Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,640.35
-25.30 (-0.69%)
At close: Aug 21, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 454.74 billion as of August 21, 2026. Its market cap has increased by 35.68% in one year.
Market Cap
454.74B
Enterprise Value
450.77B
Revenue
57.76B
Ranking
n/a
PE Ratio
40.07
Stock Price
3,640.35
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 454.74B, an increase of 80,271.89%. That is a compound annual growth rate of 31.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 454.74B | 31.50% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.01T |
| Dr. Reddy's Laboratories | 984.05B |
| Abbott India | 554.53B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 208.57B |
| Caplin Point Laboratories | 192.34B |